Journal of Dermatological Treatment

Using Biologics to Combat Psoriasis

The Journal of Dermatological Treatment is pleased to announce a new Article Collection dedicated to the groundbreaking role that biologics play in the treatment of psoriasis.

This Collection, edited by the Editors-In-Chief Dr. Steven Feldman and Prof. Dr. Peter van de Kerkhof, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, and technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

Psoriasis is a chronic inflammatory dermatological condition that typically causes the formation of scaly plaques that can be painful and itchy.  In addition to the skin manifestation, comorbidities are associated with psoriasis, including psoriatic arthritis, metabolic syndrome, cardiovascular disease and mental illness.  Generally, the course of psoriasis is chronic, sometimes cyclically as flares, but in general psoriasis persists over decades. The involvement of the skin can significantly diminish the quality of life for a patient, even leading to hospitalization. Over the last several years, a number of biologic drugs have been approved to treat the various types of psoriasis and psoriatic arthritis, leading to significant improvements in patient outcomes, with an impressive clearing capacity and long-term effective safe control of psoriasis.

While the call is open to receive manuscripts across the broad spectrum of biologics in the treatment of psoriasis, the Editors are particularly interested in manuscripts relating to the following areas:

• Cytokine blocking drugs
• Novel mechanisms of action of new candidate biologics
• Dosing and treatment strategies
• Biologic switching
• Changes in patient outcomes
• Comorbidities in psoriasis: early diagnosis and management
• Long-term efficacy and safety
• Early active intervention
• Disease modification

Submitting authors will be eligible for a discount on associated Article Publishing Charges (APC). Please contact Ashley Ambros with any queries and discount codes regarding this Article Collection.

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

The deadline for submitting manuscripts is 1^st of April 2026. 

Please submit your manuscript on our website, selecting "Using Biologics to Combat Psoriasis" from the drop-down menu for consideration in this Article Collection. Please include any discount codes before you submit as these will not be applied retrospectively.